Diabetes 50:1064-1068, 2001
© 2001 by the American Diabetes Association, Inc.
Overexpressing Human Lipoprotein Lipase in Mouse Skeletal Muscle Is Associated With Insulin Resistance
Luis D.M.C.-B. Ferreira,
Leslie K. Pulawa,
Dalan R. Jensen, and
Robert H. Eckel
University of Colorado Health Sciences Center, Division of Endocrinology, Metabolism and Diabetes, Denver, Colorado
Lipoprotein lipase (LPL) plays a rate-limiting role in triglyceride-rich lipoprotein metabolism and is expressed in most tissues. Overexpression of LPL in skeletal muscle has been linked with higher plasma glucose levels suggesting insulin resistance (Jensen et al., Am J Physiol 273:R683R689, 1997). The aim of our study was to ascertain whether the overexpression of human LPL in skeletal muscle leads to insulin resistance and to investigate the mechanism. Respiratory quotient measurements in both transgenic (MCKhLPL) and nontransgenic mice on a high-carbohydrate diet were conducted and showed a shift in fuel usage in transgenic mice when fasting but not when actively feeding. An increase in citrate and glucose 6-phosphate levels in fasted MCKhLPL mice further supports this preferential use of lipids. When challenged with an intraperitoneal injection of glucose (1 g/kg), MCKhLPL mice had a higher plasma glycemic excursion than nontransgenic mice. No differences in insulin response were observed between the two groups. Further investigation using hyperinsulinemic-euglycemic clamps revealed insulin resistance in MCKhLPL mice. Despite signs of insulin resistance, there was no associated increase in free fatty acids, hypertriglyceridemia, or hyperinsulinemia in MCKhLPL mice. In conclusion, MCKhLPL mice are insulin resistant, presumably due to increased delivery of lipoprotein-derived fatty acids to muscle.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. T. Hamilton, D. G. Hamilton, and T. W. Zderic
Role of Low Energy Expenditure and Sitting in Obesity, Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease
Diabetes,
November 1, 2007;
56(11):
2655 - 2667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Aslanidi, V. Kroutov, G. Philipsberg, K. Lamb, M. Campbell-Thompson, G. A. Walter, S. Kurenov, J. Ignacio Aguirre, P. Keller, K. Hankenson, et al.
Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
Am J Physiol Endocrinol Metab,
September 1, 2007;
293(3):
E726 - E736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P Corcoran, S. Lamon-Fava, and R. A Fielding
Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise
Am. J. Clinical Nutrition,
March 1, 2007;
85(3):
662 - 677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yokoyama, T. Seo, T. Park, H. Yagyu, Y. Hu, N. H. Son, A. S. Augustus, R. K. Vikramadithyan, R. Ramakrishnan, L. K. Pulawa, et al.
Effects of lipoprotein lipase and statins on cholesterol uptake into heart and skeletal muscle
J. Lipid Res.,
March 1, 2007;
48(3):
646 - 655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Pulawa, D. R. Jensen, A. Coates, and R. H. Eckel
Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle
J. Lipid Res.,
January 1, 2007;
48(1):
145 - 151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Chavez, W. L. Holland, J. Bar, K. Sandhoff, and S. A. Summers
Acid Ceramidase Overexpression Prevents the Inhibitory Effects of Saturated Fatty Acids on Insulin Signaling
J. Biol. Chem.,
May 20, 2005;
280(20):
20148 - 20153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Pappan, Z. Pan, G. Kwon, C. A. Marshall, T. Coleman, I. J. Goldberg, M. L. McDaniel, and C. F. Semenkovich
Pancreatic {beta}-Cell Lipoprotein Lipase Independently Regulates Islet Glucose Metabolism and Normal Insulin Secretion
J. Biol. Chem.,
March 11, 2005;
280(10):
9023 - 9029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Summers and D. H. Nelson
A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome
Diabetes,
March 1, 2005;
54(3):
591 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Duivenvoorden, B. Teusink, P. C. Rensen, J. A. Romijn, L. M. Havekes, and P. J. Voshol
Apolipoprotein C3 Deficiency Results in Diet-Induced Obesity and Aggravated Insulin Resistance in Mice
Diabetes,
March 1, 2005;
54(3):
664 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Koike, J. Liang, X. Wang, T. Ichikawa, M. Shiomi, G. Liu, H. Sun, S. Kitajima, M. Morimoto, T. Watanabe, et al.
Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity
J. Biol. Chem.,
February 27, 2004;
279(9):
7521 - 7529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Wagner, D. Kratky, G. Haemmerle, A. Hrzenjak, G. M. Kostner, E. Steyrer, and R. Zechner
Defective uptake of triglyceride-associated fatty acids in adipose tissue causes the SREBP-1c-mediated induction of lipogenesis
J. Lipid Res.,
February 1, 2004;
45(2):
356 - 365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. R. Schlaepfer, L. K. Pulawa, L. D. M. C-B. Ferreira, D. E. James, W. H. Capell, and R. H. Eckel
Increased expression of the SNARE accessory protein Munc18c in lipid-mediated insulin resistance
J. Lipid Res.,
June 1, 2003;
44(6):
1174 - 1181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Carey, J. Halliday, J. E. M. Snaar, P. G. Morris, and R. Taylor
Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects
Am J Physiol Endocrinol Metab,
April 1, 2003;
284(4):
E688 - E694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Chavez, T. A. Knotts, L.-P. Wang, G. Li, R. T. Dobrowsky, G. L. Florant, and S. A. Summers
A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids
J. Biol. Chem.,
March 14, 2003;
278(12):
10297 - 10303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Merkel, R. H. Eckel, and I. J. Goldberg
Lipoprotein lipase: genetics, lipid uptake, and regulation
J. Lipid Res.,
December 1, 2002;
43(12):
1997 - 2006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Chou, M. Haluzik, C. Gregory, K. R. Dietz, C. Vinson, O. Gavrilova, and M. L. Reitman
WY14,643, a Peroxisome Proliferator-activated Receptor alpha (PPARalpha ) Agonist, Improves Hepatic and Muscle Steatosis and Reverses Insulin Resistance in Lipoatrophic A-ZIP/F-1 Mice
J. Biol. Chem.,
June 28, 2002;
277(27):
24484 - 24489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Matzinger, P. Schneiter, and L. Tappy
Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects
Am J Physiol Endocrinol Metab,
January 1, 2002;
282(1):
E125 - E131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Voshol, M. C. Jong, V. E.H. Dahlmans, D. Kratky, S. Levak-Frank, R. Zechner, J. A. Romijn, and L. M. Havekes
In Muscle-Specific Lipoprotein Lipase-Overexpressing Mice, Muscle Triglyceride Content Is Increased Without Inhibition of Insulin-Stimulated Whole-Body and Muscle-Specific Glucose Uptake
Diabetes,
November 1, 2001;
50(11):
2585 - 2590.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|